Company profile for PhoreMost

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

PhoreMost has developed a next-generation phenotypic screening platform called SITESEEKER® that can discern the best new targets for future therapy and crucially, how to drug them. This has the potential to significantly increase the diversity of novel therapeutics for cancer and other unmet diseases. Based on the Company's core proprietary 'Protein Interference' technology, SITESEEKER systematically unmasks cryptic druggable...
PhoreMost has developed a next-generation phenotypic screening platform called SITESEEKER® that can discern the best new targets for future therapy and crucially, how to drug them. This has the potential to significantly increase the diversity of novel therapeutics for cancer and other unmet diseases. Based on the Company's core proprietary 'Protein Interference' technology, SITESEEKER systematically unmasks cryptic druggable sites across the entire human genome and directly links them to useful therapeutic functions in a live-cell context.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Building 250 Babraham Research Campus Cambridgeshire CB22 3AT
Telephone
Telephone
+44 (0)1223 804161
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20240603921740/en

BUSINESSWIRE
03 Jun 2024

https://www.businesswire.com/news/home/20240520418193/en

BUSINESSWIRE
21 May 2024

https://www.contractpharma.com/contents/view_breaking-news/2022-12-14/phoremost-and-thinkcyte-enter-strategic-research-partnership/?widget=listSection

CONTRACTPHARMA
14 Dec 2022

https://www.prnewswire.com/news-releases/phoremost-and-thinkcyte-collaborate-to-advance-ai-based-drug-discovery-301702045.html

PRNEWSWIRE
13 Dec 2022

https://www.contractpharma.com/contents/view_breaking-news/2022-09-06/phoremost-ltd-enters-multi-project-target-discovery-collaboration-with-roche/

CONTRACTPHARMA
06 Sep 2022

prnewswire.com/news-releases/vipergen-establishes-research-partnership-with-phoremost-focused-on-dna-encoded-library-del-based-drug-discovery-301375915.html

PRNEWSWIRE
14 Sep 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty